Several years ago, when Adam Fisher, Ph.D. '08, above with President David Skorton, was still a graduate student, he and colleagues dreamed up an entirely new way to synthesize human drugs called glycoproteins, which are used to treat a range of conditions from cancer to multiple sclerosis and are a fast-growing corner of the biopharmaceutical industry. On Feb. 9, a major milestone of that dream was celebrated at the opening of Cornell's McGovern Family Center for Venture Development in the Life Sciences.